Company Information

CIN
Status
Date of Incorporation
17 August 1978
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
31 August 2023
Paid Up Capital
131,438,970
Authorised Capital
250,000,000

Directors

Mammen Mathew
Mammen Mathew
Director/Designated Partner
about 2 years ago
Radhika Madhukar Dudhat
Radhika Madhukar Dudhat
Director/Designated Partner
about 2 years ago
Harsha Raghavan
Harsha Raghavan
Director/Designated Partner
over 2 years ago
Prithipal Singh Kochhar
Prithipal Singh Kochhar
Director/Designated Partner
almost 3 years ago
Rajpal Singh Kochhar
Rajpal Singh Kochhar
Director/Designated Partner
almost 3 years ago
Manish Gupta
Manish Gupta
Director/Designated Partner
almost 3 years ago
Pallavi Dinodia Gupta
Pallavi Dinodia Gupta
Director/Designated Partner
over 3 years ago
Debasis Bikash Nandy
Debasis Bikash Nandy
Director/Designated Partner
over 3 years ago
Salapaka Venkata Subha Rao
Salapaka Venkata Subha Rao
Manager/Secretary
almost 4 years ago
Bharat Sinh
Bharat Sinh
Director/Designated Partner
about 8 years ago

Past Directors

Ashok Kumar Pati
Ashok Kumar Pati
Additional Director
about 6 years ago
Ishpal Singh Ghai
Ishpal Singh Ghai
Additional Director
over 8 years ago
Jasbir Kaur Kochhar
Jasbir Kaur Kochhar
Director
almost 11 years ago
Sanjiv Kumar Dudeja
Sanjiv Kumar Dudeja
Cfo(kmp)
about 11 years ago
Govind Deo
Govind Deo
Director
about 12 years ago
Surinder Kumar Goyal
Surinder Kumar Goyal
Director
almost 20 years ago
Surender Kumar Mata
Surender Kumar Mata
Company Secretary
about 28 years ago
Amal Chandra Chakrabortti
Amal Chandra Chakrabortti
Director
over 39 years ago
Jagmohan Singh Kochhar
Jagmohan Singh Kochhar
Whole Time Director
over 47 years ago

Patents

"Parenteral Drug Delivery System"

•parenteral drug delivery system, which is pre-filled type syringe consisting of: a glass-cartridge.with one end moulded into a neck and sealed by a metal-clad rubber sea/; a needle-hub assembly, having a two-way needle mounted on the said moulded neck and duly proteileU by a needle-sheath; 3 rubber-burig to clo...

The Production Of Coated Doxycycline Hyclate Pellets."

A process for the manufacture of delayed release pellets/capsules of Doxccycline hyclate comprising, blending doxycycline hyclate, conventional ingredients, and excipients as here in described to form, granulated mass with hydroalcoholic solution, said granulated mass is passed through an extruder ...

Registered Trademarks

Praia Jagsonpal Pharmaceuticals

[Class : 3] Cosmetic Preparations Being Skin Care Cosmetics, Lotions, Body Lotions, Creams, Hair Lotions & Hair Oil

Feprotein Jagsonpal Pharmaceuticals

[Class : 5] Pharmaceuticals And Medicinal Preparation, Dietetic Substances For Medicinal Use

Ocuked Jagsonpal Pharmaceuticals

[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Humans And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin; Fungicides,...
View +236 more Brands for Jagson Pal Pharmaceuticals Limited..

Charges

0
26 October 2010
Punjab & Sind Bank
30 Lak
26 October 2010
Punjab & Sind Bank
31 Crore
26 October 2010
Punjab & Sind Bank
6 Crore
28 June 2006
Punjab & Sind Bank
19 Crore
28 June 2006
Punjab & Sind Bank
22 Crore
28 June 2006
Others
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
28 June 2006
Punjab & Sind Bank
0
28 June 2006
Others
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
28 June 2006
Punjab & Sind Bank
0
28 June 2006
Others
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
26 October 2010
Punjab & Sind Bank
0
28 June 2006
Punjab & Sind Bank
0

Documents

Form AOC-4(XBRL)-03042021_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29122020
Form MR-1-26122020_signed
Form MGT-14-26122020_signed
Copy of board resolution-26122020
Copy of shareholders resolution-26122020
Copy of certificate by the Nomination and Remuneration   Committee of the company, if any, to the effect that the remuneration is-26122020
Copy of letter of consent to act  as  Managing Director/ Whole time Director/Manager ;             -26122020
Optional Attachment-(1)-24122020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-24122020
Form MGT-15-06102020_signed
Form MSME FORM I-16092020_signed
Form MGT-14-27082020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-27082020
Form DIR-12-23012020_signed
Optional Attachment-(2)-17012020
Optional Attachment-(1)-17012020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-17012020
Form MGT-7-31122019_signed
Optional Attachment-(1)-30122019
Copy of MGT-8-30122019
List of share holders, debenture holders;-30122019
Form AOC-4(XBRL)-23112019_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-11112019
Form MSME FORM I-30102019_signed
Form DIR-12-17102019_signed
Evidence of cessation;-14102019
Optional Attachment-(2)-14102019
Optional Attachment-(1)-14102019
Form MGT-15-10102019_signed